SCHEMBL7413449

SCHEMBL7413449

COc1cccc(N2C(=O)c3c(c4ccccc4[nH]c3=O)C2=O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 0.56
ADORA1 P30542 2/20 0.56
NR1H3 Q13133 3/20 0.50
MGLL Q99685 1/20 0.48
ABCG2 Q9UNQ0 1/20 0.47
MAPT P10636 4/20 0.47
MEN1 O00255 2/20 0.47
HTT P42858 2/20 0.47
KMT2A Q03164 2/20 0.47
LMNA P02545 2/20 0.47
USP2 O75604 1/20 0.47
CYP1A2 P05177 1/20 0.44
PPARG P37231 1/20 0.44
NCOA2 Q15596 1/20 0.44
NCOA1 Q15788 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
NCOA3 Q9Y6Q9 1/20 0.44
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7410394 0.87 ADORA3 (0.54) ADORA3ADORA1NR1H3ABCG2MAPT
SCHEMBL7416738 0.85 NR1H3 (0.46) ADORA3ADORA1NR1H3MGLLMAPT
SCHEMBL7415160 0.84 ADORA3 (0.54) ADORA3ADORA1MGLLMAPTMEN1
SCHEMBL7415475 0.82 MAPT (0.49) ADORA3MAPTMEN1HTTKMT2A
SCHEMBL7418663 0.82 ADORA3 (0.54) ADORA3MGLLMAPTMEN1HTT
SCHEMBL7408875 0.78 ADORA3 (0.52) ADORA3ADORA1ABCG2MAPTMEN1
SCHEMBL7411802 0.78 ADORA3 (0.52) ADORA3ADORA1ABCG2MAPTMEN1
SCHEMBL7407990 0.74 MAPK14 (0.53) ADORA3MAPTMEN1HTTKMT2A
SCHEMBL7412697 0.74 ADORA3 (0.51) ADORA3MAPTMEN1KMT2ALMNA
SCHEMBL7409290 0.74 MAPK14 (0.53) MAPTMEN1KMT2ALMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994026741-A1 CERTAIN PYRROLOQUINOLINONES; A NEW CLASS OF GABE BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1994-11-24 WO claimed
US-5243049-A Gamma-aminobutyric acid antagonist NEUROGEN CORPORATION (US) 1993-09-07 US claimed
US-5604235-A DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP AND SEIZURE DISORDERS, BENZODIAZEPINE OVERDOSE; ENHANCEMENT OF MEMORY NEUROGEN CORPORATION (US) 1997-02-18 US disclosed
WO-1994026741-A1 CERTAIN PYRROLOQUINOLINONES; A NEW CLASS OF GABE BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1994-11-24 WO disclosed
US-5243049-A Gamma-aminobutyric acid antagonist NEUROGEN CORPORATION (US) 1993-09-07 US disclosed